Subtype
Blood Vessel Neoplasm
CI-CAN-00000567Explore in graph →
Non-malignant50 active trials4 approved drugs8 evidence items
- NCIt
- C7387
Loading cancer entity…
Subtype
CI-CAN-00000567Explore in graph →
Clinical trials
292 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02496013 | Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB | unknown | Phase 1 | 70 | Peking Union Medical College HospitalOTHER | 1 | Apr 7, 2017 | clinicaltrials |
| NCT02732678 | Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO)(PROPAN) | unknown | Phase 1 / Phase 2 | 24 | Assistance Publique Hopitaux De Marseille |
| 1 |
| Apr 11, 2016 |
| clinicaltrials |
Data updated 22 days agoSource updated Apr 7, 2017source: clinicaltrials